Bryan C Templeton's Net Worth
-$1.93 Thousand
Who is Bryan C Templeton?
Bryan C Templeton does not have any significant net worth to report based on the numbers we have. This is based on reported shares in L2 MEDICAL DEVELOPMENT CO.
SEC CIK
Bryan C Templeton's CIK is 0001586059
Past Insider Trading and Trends
2014 was Bryan C Templeton's most active year for acquiring shares with 9 total transactions. Bryan C Templeton's most active month to acquire stocks was the month of August. 2014 was Bryan C Templeton's most active year for disposing of shares, totalling 5 transactions. Bryan C Templeton's most active month to dispose stocks was the month of May. 2014 saw Bryan C Templeton paying a total of $1,328.00 for 104,991 shares, this is the most they've acquired in one year. In 2014 Bryan C Templeton cashed out on 51,398 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
L2 MEDICAL DEVELOPMENT CO No price found
CFO & TreasurerBryan C Templeton owns 23,700 units of Common Stock. In the year 2013 Bryan C Templeton filed a total of 8 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +287.36% | 25K |
$0.02 | $386.50 | 33.7K |
Dec 30 - Dec 31
| |||
Form 4
| +52.63% | 3K |
$0.06 | $180.00 | 8.7K |
May 7
| |||
Form 4
| +78.13% | 2.5K |
$0.07 | $175.00 | 5.7K |
Apr 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15 - Feb 20
| |||
Form 4
| +1,500.00% | 3K |
$0.40 | $1,200.00 | 3.2K |
Sep 9 - Oct 9
| |||
Form 4
|
∞
| 200 |
$0.64 | $128.00 | 200 |
Sep 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||